The efficacy and safety of test food consumption for 12 weeks on the visceral fat in healthy Japanese subjects: a randomized, placebo-controlled, double-blind, parallel-group study - The efficacy and safety of test food consumption for 12 weeks on the visceral fat in healthy Japanese subjects

ORTHOMEDICO Inc.0 个研究点目标入组 44 人开始时间: 2021年9月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," "Foods with Functional Claims," or other functional food/beverage in daily 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who have exercise habits three times or more per week 8. Subjects who work late-night shifts and the erratic lifestyle (particularly dietary habits) 9. Subjects who are on excessive dietary restriction, such as not eating carbohydrates at all 10. Subjects who are on a diet 11. Subjects who are pregnant, breast-feeding, and planning to become pregnant 12. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 13. Subjects who are judged as ineligible to participate in the study by the physician

发起方